Uncovering the Genetic Contribution of Human Endogenous Retroviruses to ME/CFS
Dauer: 5 Monate, Fördersumme: € 39.504
Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Dauer: 6 Monate, Fördersumme: € 35.860
Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Dauer: 48 Monate, Fördersumme: € 999.285
MEndelian Randomisation for Evaluating Medicines and Approved Pharmacotherapies in ME/CFS
Dauer: 5 Monate, Fördersumme: € 37.884
Engineering enhanced microbiome function using synthetic ecology
Dauer: 48 Monate, Fördersumme: € 897.156
Determinants of mRNA Lifetime and Translation Efficiency
Dauer: 48 Monate, Fördersumme: € 799.100